Angeline Bartholomeusz
Angeline Bartholomeusz
victorian Infectious diseases reference laboratory
Verified email at
Cited by
Cited by
Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase
P Angus, R Vaughan, S Xiong, H Yang, W Delaney, C Gibbs, C Brosgart, ...
Gastroenterology 125 (2), 292-297, 2003
Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine
DJ Tenney, SM Levine, RE Rose, AW Walsh, SP Weinheimer, L Discotto, ...
Antimicrobial agents and chemotherapy 48 (9), 3498-3507, 2004
Antiviral drug‐resistant HBV: Standardization of nomenclature and assays and recommendations for management
AS Lok, F Zoulim, S Locarnini, A Bartholomeusz, MG Ghany, ...
Hepatology 46 (1), 254-265, 2007
Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir
J Sheldon, N Camino, B Rodés, A Bartholomeusz, M Kuiper, F Tacke, ...
Antiviral therapy 10 (6), 727, 2005
Hepatitis B virus genotypes: comparison of genotyping methods
A Bartholomeusz, S Schaefer
Reviews in medical virology 14 (1), 3-16, 2004
HBV drug resistance: mechanisms, detection and interpretation
T Shaw, A Bartholomeusz, S Locarnini
Journal of hepatology 44 (3), 593-606, 2006
Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantation
GKK Lau, ML He, DYT Fong, A Bartholomeusz, W Au, AKW Lie, ...
Hepatology 36 (3), 702-709, 2002
Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy
GV Matthews, A Bartholomeusz, S Locarnini, A Ayres, J Sasaduesz, ...
Aids 20 (6), 863-870, 2006
Antiviral drug resistance: clinical consequences and molecular aspects
A Bartholomeusz, SA Locarnini
Seminars in liver disease 26 (02), 162-170, 2006
Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation
TT Aye, A Bartholomeusz, T Shaw, S Bowden, A Breschkin, J McMillan, ...
Journal of hepatology 26 (5), 1148-1153, 1997
The hepatitis B virus and common mutants
S Locarnini, J McMillan, A Bartholomeusz
Seminars in liver disease 23 (01), 005-020, 2003
Comparisons of the HBV and HIV polymerase, and antiviral resistance mutations.
A Bartholomeusz, BG Tehan, DK Chalmers
Antiviral therapy 9 (2), 149-160, 2004
Mutations affecting the replication capacity of the hepatitis B virus
J Sheldon, B Rodes, F Zoulim, A Bartholomeusz, V Soriano
Journal of viral hepatitis 13 (7), 427-434, 2006
Hepatitis B virus mutations associated with antiviral therapy
A Bartholomeusz, S Locarnini
Journal of medical virology 78 (S1), S52-S55, 2006
Epidemiological and virological characteristics of 2 subgroups of hepatitis B virus genotype C
HLY Chan, SKW Tsui, CH Tse, EYT Ng, TCC Au, L Yuen, ...
Journal of Infectious Diseases 191 (12), 2022-2032, 2005
Lamivudine therapy in patients undergoing liver transplantation for hepatitis b virus precore mutant–associated infection: High resistance rates in treatment of recurrence but …
GW McCaughan, J Spencer, D Koorey, S Bowden, A Bartholomeusz, ...
Liver Transplantation and Surgery 5 (6), 512-519, 1999
The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response …
A Robert, AI Bartholomeusz, HGM Niesters, PE Zondervan, SA Locarnini
Journal of hepatology 29 (4), 669-675, 1998
Synthesis of dengue virus RNA in vitro: initiation and the involvement of proteins NS3 and NS5
AI Bartholomeusz, PJ Wright
Archives of virology 128 (1-2), 111-121, 1993
The L80I substitution in the reverse transcriptase domain of the hepatitis B virus polymerase is associated with lamivudine resistance and enhanced viral replication in vitro
N Warner, S Locarnini, M Kuiper, A Bartholomeusz, A Ayres, L Yuen, ...
Antimicrobial agents and chemotherapy 51 (7), 2285-2292, 2007
A systematic review of T-cell epitopes in hepatitis B virus: identification, genotypic variation and relevance to antiviral therapeutics
CP Desmond, A Bartholomeusz, S Gaudieri, PA Revill, SR Lewin
Antiviral therapy 13 (2), 161, 2008
The system can't perform the operation now. Try again later.
Articles 1–20